Nadofaragene firadenovec
id:
nadofaragene-firadenovec-283-10763835
title:
Nadofaragene firadenovec
text:
Nadofaragene firadenovec, sold under the brand name Adstiladrin, is a gene therapy for the treatment of bladder cancer. It is a non-replicating adenoviral vector-based gene therapy. The most common adverse events including laboratory abnormalities, include increased glucose, instillation site discharge, increased triglycerides, fatigue, bladder spasm, micturition urgency, increased creatinine, hematuria, decreased phosphate, chills, dysuria, and pyrexia. Nadofaragene firadenovec was approved for
brand slug:
wiki
category slug:
encyclopedia
description:
Gene therapy medication
original url:
https://en.wikipedia.org/wiki/Nadofaragene_firadenovec
date created:
date modified:
2023-12-18T07:55:09Z
main entity:
{"identifier":"Q115779373","url":"https://www.wikidata.org/entity/Q115779373"}
image:
fields total:
13
integrity:
14